Synthetic biology company Twist Bioscience has joined the long list of life science firms going public this year, raising $70 million in its stock market debut.
The San Francisco company sold 5 million shares at $14 apiece, which was within the... Read more »
Teraki, a Berlin-based data processing and artificial intelligence company working in the mobility sector, has had a busy fall.
In late September, Teraki raised a $3 million seed round from investors including Paladin Capital Group, GPS Ventures GmbH,... Read more »
Before researchers at Google’s skunkworks labs embark on a new project, they decide when to kill it.
The technical and business teams set parameters for when to walk away from the “moonshot” idea to avoid being so seduced by the technology... Read more »
GlaxoSmithKline’s former gene therapy portfolio is at the center of a $200 million IPO, among the larger biopharma offerings on Wall Street over the last several years.
Orchard Therapeutics, a London, Boston, and San Francisco-based biotech, sold 14,285,715 shares in its... Read more »
Facebook (NASDAQ: FB) shares gained nearly 3 percent Tuesday, and ticked up further in after-hours trading following the release of a third quarter earnings report that showed some strengths as well as shortfalls. Investors have been concerned about the social... Read more »
It took six years for Classy, a software-as-a-service company that targets nonprofit organizations looking to fundraise online, to facilitate $500 million in donations.
But the next $500 million took just 14 months.
The San Diego-based startup announced the $1 billion milestone... Read more »
Stantt wants to make standard sizing anything but.
“Traditional sizing only fits 15 percent of guys,” says Matt Hornbuckle, the startup’s founder and co-CEO. “Twins come in and get different sizes.”
To connect guys with a shirt that fits well, the... Read more »
[Updated October 30, 12:15pm ET with further comment, see below.] The immune systems of a large majority of people could already be primed to attack and possibly even disable a key component of CRISPR-Cas9 gene editing therapeutics (which are... Read more »
In September, Backstage Capital, a venture investment firm seeding early-stage startups led by women, people of color, and members of the LGBTQ community, launched a $36 million fund to help support black women founders.
At the same time, managing... Read more »